Pacira BioSciences
PCRXAlgoritmens signaler
- ›Starkt 3m-momentum (+35.2%)
- ›Starkt 6m-momentum (+48.9%)
- ›Starkt 12m-momentum (+64.0%)
- ›Pris över MA50 och MA200 (uppåttrend)
- ›Hög volatilitet (80% årlig)
- ›+94% från 52v-botten
- ›Ökad handelsvolym (+395%)
📰 Senaste nyheter & analys
Källor: Placera, Nyhetsbyrån Direkt, Google NewsPCRX Stock Alert: Halper Sadeh LLC is Investigating Whether Pacir - The National Law Review
22 h sedanPCRX Stock Alert: Halper Sadeh LLC is Investigating Whether Pacir The National Law Review
The National Law ReviewPCRX Stock Alert: Halper Sadeh LLC is Investigating Whether Pacira BioSciences, Inc. is Obtaining a Fair Price for its Shareholders - Carroll County Mirror-Democrat
23 h sedanPCRX Stock Alert: Halper Sadeh LLC is Investigating Whether Pacira BioSciences, Inc. is Obtaining a Fair Price for its Shareholders Carroll County Mirror-Democrat
Carroll County Mirror-DemocratViatris Begins $36.50 Per Share Cash Offer for Pacira BioSciences - Yahoo Finance
1 d sedanViatris Begins $36.50 Per Share Cash Offer for Pacira BioSciences Yahoo Finance
Yahoo FinancePacira BioSciences (PCRX) Reports Next Week: Wall Street Expects Earnings Growth - Yahoo Finance
2 d sedanPacira BioSciences (PCRX) Reports Next Week: Wall Street Expects Earnings Growth Yahoo Finance
Yahoo FinanceIs Pacira BioSciences (PCRX) Stock Looking Stretched Or Reasonable? - Simply Wall St
2 d sedanIs Pacira BioSciences (PCRX) Stock Looking Stretched Or Reasonable? Simply Wall St
Simply Wall StViatris To Acquire Pacira BioSciences - What Investors Should Know (NASDAQ:VTRS) - Seeking Alpha
2026-10-09Viatris To Acquire Pacira BioSciences - What Investors Should Know (NASDAQ:VTRS) Seeking Alpha
Seeking AlphaViatris Agrees to Acquire Pacira BioSciences, Advancing Its Innovative Medicines Strategy and Becoming a Leader in Non-Opioid Pain Therapies
2026-10-08Viatris Agrees to Acquire Pacira BioSciences, Advancing Its Innovative Medicines Strategy and Becoming a Leader in Non-Opioid Pain Therapies PR Newswire PITTSBURGH and BRISBANE, Calif., Oct. 8, 2026
Pacira PharmaceuticalsPR NewswireViatris to Acquire Pacira BioSciences (PCRX) at $36.50 per Share, Stock Surges 44% - GuruFocus
2026-10-08Viatris to Acquire Pacira BioSciences (PCRX) at $36.50 per Share, Stock Surges 44% GuruFocus
GuruFocusPacira BioSciences Highlights Leading Independent Proxy Advisory Firm ISS' Recommendation to Vote "FOR" All of Pacira's Director Nominees
2026-06-01Pacira BioSciences Highlights Leading Independent Proxy Advisory Firm ISS' Recommendation to Vote "FOR" All of Pacira's Director Nominees PR Newswire BRISBANE, Calif., June 1, 2026 ISS Concludes "T
Pacira PharmaceuticalsPR NewswireDOMA Perpetual Issues & Mails Letter to Shareholders of Pacira BioSciences - Along with its Definitive Proxy Statement & WHITE Proxy Card - Urging Shareholders to Vote "FOR" DOMA's Three Highly Qualified, Independent Board Candidates
2026-05-13DOMA Perpetual Issues & Mails Letter to Shareholders of Pacira BioSciences - Along with its Definitive Proxy Statement & WHITE Proxy Card - Urging Shareholders to Vote "FOR" DOMA's Three Highly Qualif
Pacira PharmaceuticalsPR NewswireDOMA Perpetual Nominates Three Highly Qualified Candidates for the Board of Pacira BioSciences, Inc.
2026-03-12DOMA Perpetual Nominates Three Highly Qualified Candidates for the Board of Pacira BioSciences, Inc. PR Newswire MIAMI, March 12, 2026 Pacira's Stock is Down 56% Over the Last Decade and Down 68% O
Pacira PharmaceuticalsPR NewswireDOMA Perpetual Capital Management Announces Intent to Nominate Three Highly Qualified, Independent Director Candidates at 2026 Annual Meeting of Pacira BioSciences, Inc.
2025-12-30DOMA Perpetual Capital Management Announces Intent to Nominate Three Highly Qualified, Independent Director Candidates at 2026 Annual Meeting of Pacira BioSciences, Inc. PR Newswire MIAMI, Dec. 30, 20
Pacira PharmaceuticalsPR NewswireDOMA Perpetual Sends Letter Calling for the Board of Directors of Pacira BioSciences, Inc. to Immediately Explore a Sale of the Business
2025-11-11DOMA Perpetual Sends Letter Calling for the Board of Directors of Pacira BioSciences, Inc. to Immediately Explore a Sale of the Business PR Newswire MIAMI, Nov. 10, 2025 DOMA Controls 6.8%
Pacira PharmaceuticalsPR NewswireInvestors who lost money with shares of Pacira BioSciences, Inc. (NASDAQ: PCRX) should contact the Shareholders Foundation in connection with Lawsuit
2025-07-16Investors who lost money with shares of Pacira BioSciences, Inc. (NASDAQ: PCRX) should contact the Shareholders Foundation in connection with Lawsuit PR Newswire SAN DIEGO, July 16, 2025 SAN DIEGO
Pacira PharmaceuticalsPR NewswireLawsuit for Investors in shares of Pacira BioSciences, Inc. (NASDAQ: PCRX) announced by the Shareholders Foundation
2025-05-13Lawsuit for Investors in shares of Pacira BioSciences, Inc. (NASDAQ: PCRX) announced by the Shareholders Foundation PR Newswire SAN DIEGO, May 13, 2025 SAN DIEGO , May 13, 2025 /PRNewswire/ --
Pacira PharmaceuticalsPR NewswireDOMA Perpetual Supports Pacira's New $300 Million Share Repurchase Authorization as a Meaningful Step to Enhance Value for Shareholders
2025-04-21DOMA Perpetual Supports Pacira's New $300 Million Share Repurchase Authorization as a Meaningful Step to Enhance Value for Shareholders PR Newswire MIAMI, April 21, 2025 DOMA Perpetual Believes Pac
Pacira PharmaceuticalsPR Newswire
Klicket på "Köp i Nordnet" öppnar din Nordnet-app om installerad — där loggar du in med BankID. Annars öppnas Nordnets webbsajt där du kan logga in med BankID på samma sätt.